Testosterone valerate
Clinical data | |
---|---|
Trade names | Deposterona |
Other names | Testosterone pentanoate; Testosterone 17β-valerate; Androst-4-en-17β-ol-3-one 17β-valerate |
Routes of administration | Intramuscular injection |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.559 |
Chemical and physical data | |
Formula | C24H36O3 |
Molar mass | 372.549 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Testosterone valerate, or testosterone pentanoate, also known as androst-4-en-17β-ol-3-one 17β-valerate, is a synthetic, steroidal androgen and an androgen ester – specifically, the C17β valerate ester of testosterone – which is used in veterinary medicine.[1] It is administered via intramuscular injection and acts as a long-lasting prodrug of testosterone.[1] The medication is available as a component of the veterinary drug Deposterona, which is marketed in Mexico and also contains testosterone acetate and testosterone undecanoate.[1] Testosterone valerate is a short-to-medium duration ester of testosterone, with an elimination half-life of approximately twice that of the short-acting testosterone propionate.[1]
See also
References
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.